SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-20-060185
Filing Date
2020-05-12
Accepted
2020-05-12 16:16:04
Documents
64
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tm2014509d1_10q.htm 10-Q 416139
2 EXHIBIT 31.1 tm2014509d1_31-1.htm EX-31.1 7135
3 EXHIBIT 31.2 tm2014509d1_31-2.htm EX-31.2 7136
4 EXHIBIT 32.1 tm2014509d1_32-1.htm EX-32.1 3833
5 EXHIBIT 32.2 tm2014509d1_32-2.htm EX-32.2 3898
  Complete submission text file 0001104659-20-060185.txt   3559176

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ards-20200331.xml EX-101.INS 698081
7 XBRL TAXONOMY EXTENSION SCHEMA ards-20200331.xsd EX-101.SCH 40027
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ards-20200331_cal.xml EX-101.CAL 32662
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ards-20200331_def.xml EX-101.DEF 138343
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ards-20200331_lab.xml EX-101.LAB 369827
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ards-20200331_pre.xml EX-101.PRE 281363
Mailing Address 5941 OPTICAL COURT SAN JOSE CA 95138
Business Address 5941 OPTICAL COURT SAN JOSE CA 95138 (408) 385-1742
Aridis Pharmaceuticals, Inc. (Filer) CIK: 0001614067 (see all company filings)

IRS No.: 320074500 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38630 | Film No.: 20869307
SIC: 2834 Pharmaceutical Preparations